Cas 59618-87-0,[3aR,4R(1E),5R,6aS]-5-(benzoyloxy)-4-[4-phenoxy-3,3-(ethylenedioxy)butenyl]-hexahydro-2H-cyclopenta[b]furan-2-one

59618-87-0

Post Buying Request

Basic information

Product Name: [3aR,4R(1E),5R,6aS]-5-(benzoyloxy)-4-[4-phenoxy-3,3-(ethylenedioxy)butenyl]-hexahydro-2H-cyclopenta[b]furan-2-one
Synonyms: [3aR,4R(1E),5R,6aS]-5-(benzoyloxy)-4-[4-phenoxy-3,3-(ethylenedioxy)butenyl]-hexahydro-2H-cyclopenta[b]furan-2-one
CAS NO:59618-87-0
Molecular Formula:
Molecular Weight: 450.488
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: [3aR,4R(1E),5R,6aS]-5-(benzoyloxy)-4-[4-phenoxy-3,3-(ethylenedioxy)butenyl]-hexahydro-2H-cyclopenta[b]furan-2-one(CAS DataBase Reference)
NIST Chemistry Reference: [3aR,4R(1E),5R,6aS]-5-(benzoyloxy)-4-[4-phenoxy-3,3-(ethylenedioxy)butenyl]-hexahydro-2H-cyclopenta[b]furan-2-one(59618-87-0)
EPA Substance Registry System: [3aR,4R(1E),5R,6aS]-5-(benzoyloxy)-4-[4-phenoxy-3,3-(ethylenedioxy)butenyl]-hexahydro-2H-cyclopenta[b]furan-2-one(59618-87-0)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 59618-87-0(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

59618-87-0 Suppliers

Recommended suppliers

59618-87-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 59618-87-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,9,6,1 and 8 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 59618-87:
(7*5)+(6*9)+(5*6)+(4*1)+(3*8)+(2*8)+(1*7)=170
170 % 10 = 0
So 59618-87-0 is a valid CAS Registry Number.

59618-87-0Upstream product

59618-87-0Downstream Products

59618-87-0Relevant academic research and scientific papers

15-ketal postaglandins for the treatment of glaucoma or ocular hypertension

-

Page column 20-21, (2010/11/29)

A method of treating glaucoma or ocular hypertension in a patient, which comprises administering to the patient a pharmaceutically effective amount of a compound of formula I:

15-Ethylenedioxy-prostanoic acid derivatives and esters thereof and intermediates thereof

-

, (2008/06/13)

Prostanoic acid derivatives of the formula STR1 wherein R1 is a hydrogen atom, alkyl of 1-10 carbon atoms, aryl or --CH2 --U--V wherein U is a direct bond, carbonyl, or carbonyloxy and V is phenyl or substituted phenyl, e.g. substitu

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 59618-87-0